These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2907563)

  • 1. Selective beta 2-adrenoceptor antagonists: derivatives of ICI 118,551 and a binary aryloxypropanolamine.
    Nathanson JA; Hunnicutt EJ
    J Pharm Pharmacol; 1988 Nov; 40(11):803-5. PubMed ID: 2907563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process.
    Nathanson JA
    J Pharmacol Exp Ther; 1988 Apr; 245(1):94-101. PubMed ID: 2896241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and physiological effects of S-32-468, a beta-adrenoceptor antagonist with possible oculoselectivity.
    Nathanson JA
    Curr Eye Res; 1985 Mar; 4(3):191-7. PubMed ID: 2861973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism of the responses to isoproterenol in the rat hippocampal slice with subtype-selective antagonists.
    Fowler JC; O'Donnell JM
    Eur J Pharmacol; 1988 Aug; 153(1):105-10. PubMed ID: 2905663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
    Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
    [No Abstract]   [Full Text] [Related]  

  • 11. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor studies. 5. 1H NMR and IR spectroscopic analysis of the conformation of the hydrohalide salts of beta-adrenoceptor-blocking aryloxypropanolamines. Evidence for a seven-membered ring structure with participation of two hydrogen bonds.
    Zaagsma J
    J Med Chem; 1979 Apr; 22(4):441-9. PubMed ID: 34723
    [No Abstract]   [Full Text] [Related]  

  • 13. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 14. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
    Smith LH; Tucker H
    J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heart.
    Nathanson JA
    J Pharmacol Exp Ther; 1985 Jan; 232(1):119-26. PubMed ID: 2856938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of pharmacological properties of various potential beta adrenolytics of the aryloxypropanolamine type].
    Béderová E; Edelsteinová S; Racanský V; Svec P
    Cesk Farm; 1982 Sep; 31(7):279-85. PubMed ID: 6128077
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of a beta-2 selective adrenergic receptor antagonist (ICI 118,551) on twitch tension in cat soleus muscle.
    Smith HJ; Halliday SE; Rouse W
    J Pharmacol Exp Ther; 1983 Jan; 224(1):228-30. PubMed ID: 6129319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and pharmacological investigation of ether derivatives of 3-amino-1,2,-propanediol, I].
    Georgiev A; Tschalina E; Petkov W; Manolov P
    Arch Pharm (Weinheim); 1979 Nov; 312(11):881-91. PubMed ID: 44461
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.
    Amlaiky N; Leclerc G
    J Pharm Sci; 1985 Oct; 74(10):1117-9. PubMed ID: 2867200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.